Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 RANKing c-Jun in osteoclast development.

× No keyword cloud information.

21 in total

Review 1. Partners in transcription: NFAT and AP-1.

Authors: F Macián; C López-Rodríguez; A Rao
Journal: Oncogene Date: 2001-04-30 Impact factor: 9.867

2. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.

Authors: K Matsuo; J M Owens; M Tonko; C Elliott; T J Chambers; E F Wagner
Journal: Nat Genet Date: 2000-02 Impact factor: 38.330

3. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice.

Authors: A Naito; S Azuma; S Tanaka; T Miyazaki; S Takaki; K Takatsu; K Nakao; K Nakamura; M Katsuki; T Yamamoto; J Inoue
Journal: Genes Cells Date: 1999-06 Impact factor: 1.891

4. Regulation of the murine Nfatc1 gene by NFATc2.

Authors: Bin Zhou; Randy Q Cron; Bingruo Wu; Anna Genin; Zhili Wang; Steve Liu; Paul Robson; H Scott Baldwin
Journal: J Biol Chem Date: 2002-01-10 Impact factor: 5.157

5. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.

Authors: Jean-Pierre David; Kanaga Sabapathy; Oskar Hoffmann; Maria H Idarraga; Erwin F Wagner
Journal: J Cell Sci Date: 2002-11-15 Impact factor: 5.285

6. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism.

Authors: J Li; I Sarosi; X Q Yan; S Morony; C Capparelli; H L Tan; S McCabe; R Elliott; S Scully; G Van; S Kaufman; S C Juan; Y Sun; J Tarpley; L Martin; K Christensen; J McCabe; P Kostenuik; H Hsu; F Fletcher; C R Dunstan; D L Lacey; W J Boyle
Journal: Proc Natl Acad Sci U S A Date: 2000-02-15 Impact factor: 11.205

Review 7. Bone resorption by osteoclasts.

Authors: S L Teitelbaum
Journal: Science Date: 2000-09-01 Impact factor: 47.728

8. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.

Authors: J Lam; S Takeshita; J E Barker; O Kanagawa; F P Ross; S L Teitelbaum
Journal: J Clin Invest Date: 2000-12 Impact factor: 14.808

9. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.

Authors: S Srivastava; G Toraldo; M N Weitzmann; S Cenci; F P Ross; R Pacifici
Journal: J Biol Chem Date: 2000-12-19 Impact factor: 5.157

10. Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity.

Authors: J Lam; C A Nelson; F P Ross; S L Teitelbaum; D H Fremont
Journal: J Clin Invest Date: 2001-10 Impact factor: 14.808

25 in total

Review 1. Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors: Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal: Crit Rev Eukaryot Gene Expr Date: 2009 Impact factor: 1.807

2. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.

Authors: Jong-Ho Lee; Ha-Neui Kim; Daum Yang; Kyoungsuk Jung; Hyun-Man Kim; Hong-Hee Kim; Hyunil Ha; Zang Hee Lee
Journal: J Biol Chem Date: 2009-03-19 Impact factor: 5.157

3. N-(2-Hydroxyphenyl)acetamide: a Novel Suppressor of RANK/RANKL Pathway in Collagen-Induced Arthritis Model in Rats.

Authors: Anum Gul; Bimal Kunwar; Maryam Mazhar; Kahkashan Perveen; Shabana U Simjee
Journal: Inflammation Date: 2017-08 Impact factor: 4.092

4. RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.

Authors: Shuying Yang; Yi-Ping Li
Journal: J Bone Miner Res Date: 2007-01 Impact factor: 6.741

5. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.

Authors: Ji-Won Lee; Ayumi Iwahashi; Shin-ichi Hasegawa; Takayuki Yonezawa; Won Bae Jeon; Byung-Yoon Cha; Kazuo Nagai; Je-Tae Woo
Journal: J Nat Med Date: 2011-06-09 Impact factor: 2.343

6. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors: Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal: Clin Rheumatol Date: 2006-04-04 Impact factor: 2.980

7. Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.

Authors: Jesse E Otero; Simon Dai; Domenica Foglia; Muhammad Alhawagri; Jean Vacher; Manolis Pasparakis; Yousef Abu-Amer
Journal: J Biol Chem Date: 2008-06-19 Impact factor: 5.157

8. 6-Shogaol promotes bone resorption and accelerates orthodontic tooth movement through the JNK-NFATc1 signaling axis.

Authors: Xiaofang Zhu; Hao Yuan; Ouyang Ningjuan; Carroll Ann Trotman; Thomas E Van Dyke; Jake Jinkun Chen; Guofang Shen
Journal: J Bone Miner Metab Date: 2021-06-30 Impact factor: 2.626

9. MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation.

Authors: Michael S Valerio; Bethany A Herbert; Alfred C Griffin; Zhuang Wan; Elizabeth G Hill; Keith L Kirkwood
Journal: Bone Date: 2013-11-20 Impact factor: 4.398

10. Patient specific proteolytic activity of monocyte-derived macrophages and osteoclasts predicted with temporal kinase activation states during differentiation.

Authors: Keon-Young Park; Weiwei A Li; Manu O Platt
Journal: Integr Biol (Camb) Date: 2012-12 Impact factor: 2.192